WALDNER Brief - Nr. 170.pdf - Waldner Firmengruppe
WALDNER Brief - Nr. 170.pdf - Waldner Firmengruppe
WALDNER Brief - Nr. 170.pdf - Waldner Firmengruppe
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
India – a continent with many faces<br />
What does the future hold after the financial and economic crisis?<br />
An attempt to describe possible development in the future.<br />
by professor Franz Maier, Nycomed (deutsche Version siehe Seite 4)<br />
The traditional emerging nations – India, China and<br />
Brazil – have shown ever since the economic and financial<br />
crisis that they have survived this recession<br />
surprisingly well. A large part of these countries has<br />
"weathered" the turmoil in the financial markets better<br />
than many western industrial countries (one need only<br />
think of Greece within the EU, and possibly also Portugal<br />
and Spain) and are now emerging as the victors<br />
of the crisis.<br />
SCALA-Laborarbeitsplätze im Produktionslabor.<br />
scaLa laboratory work benches in the production laboratory.<br />
This is evident above all from the growth rates of these<br />
countries: 8.9% in China, followed by an anticipated<br />
8.8% for India this year. A fundamental shift in the economical<br />
and financial balance of power towards the emerging<br />
markets has been evident for some years. The percentage<br />
of global economic output generated by these countries has<br />
been increasing significantly over recent years and has been<br />
more than 50% since 2009.<br />
Hard times have fallen on the pharmaceutical industry in<br />
the industrial nations and never before have so many drugs<br />
lost their patent protection as is the case today. This is<br />
down to the imitators and generic drugs companies, many<br />
of whom are located in India, who are generating massive<br />
pressure. In 2010 pharmaceuticals with a market value of<br />
25 billion dollars lost their patent protection. Statistics assume<br />
that there are over 3,000 pharmaceutical companies in<br />
India, 300 of which are regarded as being "large".<br />
SCALA-Doppelarbeitstische bei der Firma Zydus Nycomed in Indien.<br />
scaLa double work benches at zydus nycomed in india.<br />
Sooner or later you will be asking yourself what has <strong>Waldner</strong><br />
got to do with India? It was around five years ago that<br />
the story started with <strong>WALDNER</strong> Laboreinrichtungen, India<br />
and ALTANA in Konstanz. Since the mid-1990s ALTANA has<br />
been operating in India and was planning a 50:50 joint venture<br />
in India with one of the largest Indian pharmaceutical<br />
companies, Achmedabad-based Zydus Cadilla. The business<br />
hub of Mumbai was a possible location in India, as this city<br />
and its surroundings accounts for 40% of economic output in<br />
India and is the key business heart of the country.<br />
We created a wonderful "campus architectural style" in a<br />
formal Botanical Garden, whilst paying the greatest attention<br />
to and retaining the existing environmental structures<br />
as well as striving for and achieving sustainability. The<br />
furniture systems, including a number of laboratory flue<br />
cupboards, were supplied by <strong>Waldner</strong>, which emerged as the<br />
winner of the international competition. The mc6 range was<br />
the premium quality defining product that, with its many<br />
well-known innovations, is still satisfying, enthusing and<br />
inspiring laboratory staff today.<br />
eVents & neWs<br />
7